Ovulation stimulation protocols utilizing GnRH-antagonist/hCG, promote cytotoxic cell populations, predominant in patients with embryo implantation complications

Neuroendocrinology Letters

Volumn 34, Issue 3, 2013, Pages 249-257

  Svoboda, Jan ^a   Ruzickova, Zaneta ^a   Cuchalova, Lucie ^b   Kralickova, Milena ^c   Rezacova, Jitka ^d   Vrana, Milena ^e   Fiserova, Anna ^a,f   Richter, Jan ^a   Madar, Jindrich ^d  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^e INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^f CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

CD4 CD8 index; Chorionic gonadotropin; Embryo implantation; Gonadotropin releasing hormone; KIR2DL4 receptor; LILRB1 receptor; Natural killer cells; Ovulation induction; T lymphocytes

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST; HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4;

ADULT; AGE; ARTICLE; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR DISTRIBUTION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FEMALE INFERTILITY; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; NATURAL KILLER CELL; NIDATION; OOCYTE MATURATION; OVARY FOLLICLE FLUID; OVULATION INDUCTION; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 84878952245     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abu Alshamat E, Al-Okla S, Soukkarieh CH, Kweider M (2012). Human chorionic gonadotrophin (hCG) enhances immunity against L. tropica by stimulating human macrophage functions. Parasite Immunol. 34: 449-454.
2. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P (1997). Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril. 67: 917-922. (Pubitemid 27183922)
3. Apps R, Gardner L, Moffett A (2008). A critical look at HLA-G. Trends Immunol. 29: 313-321.
4. Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S (2005). Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 84: 555-569. (Pubitemid 41317707)
5. Bower C, Hansen M (2005). Assisted reproductive technologies and birth outcomes: overview of recent systematic reviews. Reprod Fertil Dev 17: 329-333. (Pubitemid 40425686)
6. Brown D, Trowsdale J, Allen R (2004). The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens. 64: 215-225. (Pubitemid 39120446)
7. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D (1991). Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod. 6: 791-798.
8. Caputo M, Nicotra M, Gloria-Bottini E (2008), Fertility Transition: Forecast for Demography. Hum Biol. 80: 359-376.
9. Carosella ED (2011). The tolerogenic molecule HLA-G. Immunol Lett. 138: 22-24.
10. CDC (2010). http://www.cdc.gov/art/ART2010/PDFs/01-ART-2010-Clinic- Report-FM.pdf
11. Chaouat G, Dubanchet S, Ledee N (2007a). Cytokines: Important for implantation? J Assist Reprod Genet. 24: 491-505. (Pubitemid 50005730)
12. Chaouat G, Mas AE, Petitbarat M, Dubanchet S, Ledee N (2007b). Physiology of implantation. Gynecol Obstet Fertil. 35: 861-866.
13. De Maria A, Bozzano F, Cantoni C, Moretta L (2011). Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A. 108: 728-732.
14. ESHRE (2009). http://www.eshre.eu/ESHRE/English/Guidelines-Legal/ART- fact-sheet/page.aspx/1061)
15. Fainaru O, Amsalem H, Bentov Y, Esfandiari N, Casper RF (2010). CD56(bright)CD16(-) natural killer cells accumulate in the ovarian follicular fluid of patients undergoing in vitro fertilization. Fertil Steril. 94: 1918-1921.
16. Faure M, Long EO (2002). KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol. 168: 6208-6214. (Pubitemid 34620040)
17. Giuliani A, Schoell W, Auner J, Urdl W (1998). Controlled ovarian hyperstimulation in assisted reproduction: effect on the immune system. Fertil Steril. 70: 831-835.
18. Goodridge JP, Witt CS, Christiansen FT, Warren HS (2003). KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 171: 1768-1774. (Pubitemid 36966459)
19. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, Claas FH, Walker JJ, Redman CW, Morgan L, Tower C, Regan L, Moore GE, Carrington M, Moffett A (2010). Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 120: 4102-4110.
20. Hoozemans DA, Schats R, Lambalk CB, Homburg R, Hompes PG (2004). Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reprod Biomed Online. 9: 692-715. (Pubitemid 40028888)
21. Hunt JS, Langat DL (2009). HLA-G: a human pregnancy-related immunomodulator. Curr Opin Pharmacol. 9: 462-469.
22. Hunt JS, Petroff MG, McIntire RH, Ober C (2005). HLA-G and immune tolerance in pregnancy. FASEB J. 19: 681-693. (Pubitemid 40617373)
23. Karami N, Boroujerdnia MG, Nikbakht R, Khodadadi A (2012). Enhancement of peripheral blood CD56(dim) cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. J Reprod Immunol. 95: 87-92.
24. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS (2003). KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol. 171: 3415-3425. (Pubitemid 37254542)
25. Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2003). Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril. 79: 873-880. (Pubitemid 36385006)
26. Lachapelle MH, Hemmings R, Roy DC, Falcone T, Miron P (1996). Flow cytometric evaluation of leukocyte subpopulations in the follicular fluids of infertile patients. Fertil Steril 65: 1135-1140. (Pubitemid 26163274)
27. Le Bouteiller P, Tabiasco J (2006). Killers become builders during pregnancy. Nat Med 12: 991-992. (Pubitemid 44353372)
28. Loke YW, King A (1995). Human implantation: cell biology and immunology. Cambridge University Press, Cambridge; New York.
29. Lopez-Botet M, Llano M, Navarro F, Bellon T (2000). NK cell recognition of non-classical HLA class I molecules. Semin Immunol. 12: 109-119. (Pubitemid 30199275)
30. Lukassen HG, van der Meer A, van Lierop MJ, Lindeman EJ, Joosten I, Braat DD (2003). The proportion of follicular fluid CD16+CD56DIM NK cells is increased in IVF patients with idiopathic infertility. J Reprod Immunol 60: 71-84. (Pubitemid 37272297)
31. Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton WF, Huynh D (1989). Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril. 51: 455-459. (Pubitemid 19083658)
32. Miah SM, Hughes TL, Campbell KS (2008). KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules. J Immunol. 180: 2922-2932.
33. Middleton D, Gonzelez F (2010). The extensive polymorphism of KIR genes. Immunology. 129: 8-19.
34. Moffett-King A (2002). Natural killer cells and pregnancy. Nat Rev Immunol. 2: 656-663.
35. Moysey RK, Li Y, Paston SJ, Baston EE, Sami MS, Cameron BJ, Gavarret J, Todorov P, Vuidepot A, Dunn SM, Pumphrey NJ, Adams KJ, Yuan F, Dennis RE, Sutton DH, Johnson AD, Brewer JE, Ashfield R, Lissin NM, Jakobsen BK (2010). High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+)T cell activation. Protein Cell. 1: 1118-1127.
36. Muasher SJ (1992). Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization. Clin Ther. 14(Suppl A): 74-86.
37. Rajagopalan S, Fu J, Long EO (2001). Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol. 167: 1877-1881. (Pubitemid 32747490)
38. Sacks G, Yang Y, Gowen E, Smith S, Fay L, Chapman M (2012). Detailed analysis of peripheral blood natural killer cells in women with repeated IVF failure. Am J Reprod Immunol. 67: 434-442.
39. Saito S, Nakashima A, Myojo-Higuma S, Shiozaki A (2008). The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol. 77: 14-22.
40. Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, Ichijo M (1993). Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol. 5: 559-563. (Pubitemid 23162525)
41. Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH (2009). Expression of NK cell receptors on decidual T cells in human pregnancy. J Reprod Immunol. 80: 22-32.
42. Trowsdale J, Moffett A (2008). NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol. 20: 317-320.
43. Verloes A, Van de Velde H, LeMaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M (2011). HLA-G expression in human embryonic stem cells and preimplantation embryos. J Immunol. 186: 2663-2671.
44. Wan H, Coppens JMC, van Helden-Meeuwsen CG, Leenen PJM, van Rooijen N, Khan NA, Kiekens RCM, Benner R, Versnel MA (2009). Chorionic gonadotropin alleviates thioglycollate-induced peritonitis by affecting macrophage function. J Leukocyte Biol. 86: 361-370.
45. Wan H, Versnel MA, Leijten LME, van Helden-Meeuwsen CG, Fekkes D, Leenen PJM, Khan NA, Benner R, Kiekens RCM (2008). Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J Leukocyte Biol. 83: 894-901. (Pubitemid 351959869)